Annual Accounts Receivable
$1.17 M
-$198.00 K-14.53%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual accounts receivable is $1.17 million, with the most recent change of -$198.00 thousand (-14.53%) on December 1, 2023.
- During the last 3 years, CATX annual accounts receivable has fallen by -$848.00 thousand (-42.13%).
- CATX annual accounts receivable is now -43.00% below its all-time high of $2.04 million, reached on June 1, 2020.
Performance
CATX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$217.00 K
+$75.00 K+52.82%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly accounts receivable is $217.00 thousand, with the most recent change of +$75.00 thousand (+52.82%) on September 1, 2024.
- Over the past year, CATX quarterly accounts receivable has dropped by -$1.51 million (-87.46%).
- CATX quarterly accounts receivable is now -89.89% below its all-time high of $2.15 million, reached on March 1, 2020.
Performance
CATX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CATX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.5% | -87.5% |
| 3 y3 years | -42.1% | -84.1% |
| 5 y5 years | +0.9% | -84.1% |
CATX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.1% | at low | -89.9% | +52.8% |
| 5 y | 5-year | -43.0% | +0.9% | -89.9% | +52.8% |
| alltime | all time | -43.0% | -100.0% | -89.9% | -100.0% |
Perspective Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $217.00 K(+52.8%) |
| Jun 2024 | - | $142.00 K(-85.8%) |
| Mar 2024 | - | $999.00 K(-14.2%) |
| Dec 2023 | $1.17 M(-14.5%) | $1.17 M(-32.7%) |
| Sep 2023 | - | $1.73 M(+55.5%) |
| Jun 2023 | - | $1.11 M(-18.4%) |
| Mar 2023 | - | $1.36 M(+12.4%) |
| Dec 2022 | $1.36 M(-15.2%) | - |
| Sep 2022 | - | $1.21 M(-24.6%) |
| Jun 2022 | - | $1.61 M(-24.9%) |
| Jun 2022 | $1.61 M(-20.1%) | - |
| Mar 2022 | - | $2.14 M(+29.9%) |
| Dec 2021 | - | $1.65 M(-13.4%) |
| Sep 2021 | - | $1.90 M(-5.5%) |
| Jun 2021 | $2.01 M(-1.5%) | - |
| Jun 2021 | - | $2.01 M(-0.3%) |
| Mar 2021 | - | $2.02 M(+16.2%) |
| Dec 2020 | - | $1.74 M(-1.1%) |
| Sep 2020 | - | $1.76 M(-14.0%) |
| Jun 2020 | $2.04 M(+77.1%) | $2.04 M(-4.8%) |
| Mar 2020 | - | $2.15 M(+52.4%) |
| Dec 2019 | - | $1.41 M(-7.4%) |
| Sep 2019 | - | $1.52 M(+31.8%) |
| Jun 2019 | $1.15 M(-3.2%) | $1.15 M(+3.4%) |
| Mar 2019 | - | $1.12 M(+0.8%) |
| Dec 2018 | - | $1.11 M(+3.4%) |
| Sep 2018 | - | $1.07 M(-10.2%) |
| Jun 2018 | $1.19 M(+64.2%) | $1.19 M(+22.9%) |
| Mar 2018 | - | $970.00 K(-1.7%) |
| Dec 2017 | - | $987.00 K(+32.8%) |
| Sep 2017 | - | $743.00 K(+2.3%) |
| Jun 2017 | $726.00 K(+20.0%) | $726.00 K(-15.0%) |
| Mar 2017 | - | $854.00 K(+36.2%) |
| Dec 2016 | - | $627.00 K(+9.2%) |
| Sep 2016 | - | $574.00 K(-5.1%) |
| Jun 2016 | $605.00 K(-42.3%) | $605.00 K(-31.5%) |
| Mar 2016 | - | $883.70 K(-9.4%) |
| Dec 2015 | - | $975.30 K(-13.7%) |
| Sep 2015 | - | $1.13 M(+7.8%) |
| Jun 2015 | $1.05 M | $1.05 M(+1.0%) |
| Mar 2015 | - | $1.04 M(+30.2%) |
| Dec 2014 | - | $797.40 K(-17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $962.30 K(+5.4%) |
| Jun 2014 | $913.00 K(-1.2%) | $913.00 K(+13.4%) |
| Mar 2014 | - | $805.30 K(-12.2%) |
| Dec 2013 | - | $917.20 K(-4.7%) |
| Sep 2013 | - | $962.30 K(+4.2%) |
| Jun 2013 | $923.80 K(+6.8%) | $923.80 K(+11.3%) |
| Mar 2013 | - | $830.00 K(+26.5%) |
| Dec 2012 | - | $656.20 K(-22.4%) |
| Sep 2012 | - | $845.10 K(-2.3%) |
| Jun 2012 | $865.10 K(+9.1%) | $865.10 K(+1.4%) |
| Mar 2012 | - | $853.10 K(+2.9%) |
| Dec 2011 | - | $828.90 K(-14.8%) |
| Sep 2011 | - | $972.40 K(+22.7%) |
| Jun 2011 | $792.80 K(-11.5%) | $792.80 K(-13.0%) |
| Mar 2011 | - | $911.30 K(-9.7%) |
| Dec 2010 | - | $1.01 M(+21.1%) |
| Sep 2010 | - | $833.30 K(-7.0%) |
| Jun 2010 | $896.30 K(+20.1%) | $896.30 K(+2.7%) |
| Mar 2010 | - | $872.60 K(-5.3%) |
| Dec 2009 | - | $921.40 K(+15.3%) |
| Sep 2009 | - | $799.40 K(+7.1%) |
| Jun 2009 | $746.60 K(-26.6%) | $746.60 K(-13.6%) |
| Mar 2009 | - | $864.10 K(+4.1%) |
| Dec 2008 | - | $830.10 K(-8.9%) |
| Sep 2008 | - | $911.30 K(-10.3%) |
| Jun 2008 | $1.02 M(-7.0%) | $1.02 M(+25.7%) |
| Mar 2008 | - | $808.70 K(-2.6%) |
| Dec 2007 | - | $829.90 K(-17.7%) |
| Sep 2007 | - | $1.01 M(-7.8%) |
| Jun 2007 | $1.09 M(+83.2%) | $1.09 M(-12.1%) |
| Mar 2007 | - | $1.24 M(+26.6%) |
| Dec 2006 | - | $982.00 K(+50.5%) |
| Sep 2006 | - | $652.30 K(+9.4%) |
| Jun 2006 | $596.40 K(>+9900.0%) | $596.40 K(+0.5%) |
| Mar 2006 | - | $593.30 K(+26.9%) |
| Dec 2005 | - | $467.60 K(+243.8%) |
| Sep 2005 | - | $136.00 K(>+9900.0%) |
| Sep 1999 | $0.00(-100.0%) | $0.00 |
| Sep 1998 | $70.00 K(+53.2%) | - |
| Sep 1997 | $45.70 K(-71.2%) | - |
| Sep 1996 | $158.50 K(+647.6%) | - |
| Sep 1995 | $21.20 K(-5.4%) | - |
| Sep 1994 | $22.40 K | - |
FAQ
- What is Perspective Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Perspective Therapeutics?
- What is Perspective Therapeutics annual accounts receivable year-on-year change?
- What is Perspective Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly accounts receivable year-on-year change?
What is Perspective Therapeutics annual accounts receivable?
The current annual accounts receivable of CATX is $1.17 M
What is the all time high annual accounts receivable for Perspective Therapeutics?
Perspective Therapeutics all-time high annual accounts receivable is $2.04 M
What is Perspective Therapeutics annual accounts receivable year-on-year change?
Over the past year, CATX annual accounts receivable has changed by -$198.00 K (-14.53%)
What is Perspective Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of CATX is $217.00 K
What is the all time high quarterly accounts receivable for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly accounts receivable is $2.15 M
What is Perspective Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, CATX quarterly accounts receivable has changed by -$1.51 M (-87.46%)